Literature DB >> 11600380

High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

P R Hsueh1, L J Teng, L N Lee, S W Ho, P C Yang, K T Luh.   

Abstract

The in vitro susceptibilities of 266 isolates of Streptococcus agalactiae determined by the agar dilution method showed that 6% of isolates were nonsusceptible to penicillin and 46% was resistant to erythromycin. Of the erythromycin-resistant isolates, 86.3% had the macrolide-lincosamide-streptogramin (MLS) resistance phenotype (constitutive MLS, 85.5%; inducible MLS, 0.8%) and 13.7% had the M phenotype.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11600380      PMCID： PMC90806          DOI： 10.1128/AAC.45.11.3205-3208.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  31 in total

1.  Serotypes and antimicrobial susceptibility of group B streptococcus isolated from neonates in Casablanca.

Authors:  R Aitmhand; N Moustaoui; H Belabbes; N Elmdaghri; M Benbachir
Journal:  Scand J Infect Dis       Date:  2000

2.  Group B streptococcal infections in children: the changing spectrum of infections in infants.

Authors:  Y J Yang; C C Liu; S M Wang
Journal:  J Microbiol Immunol Infect       Date:  1998-06       Impact factor: 4.399

3.  Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.

Authors:  C J Baker; B J Webb; F F Barrett
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

4.  Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season.

Authors:  P R Hsueh; Y C Liu; J M Shyr; T L Wu; J J Yan; J J Wu; H S Leu; Y C Chuang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Resistance of Streptococcus agalactiae to erythromycin.

Authors:  G Von Recklinghausen; W Fischer; K Schmidt; R Ansorg
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

6.  Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin.

Authors:  J M Dixon; A E Lipinski
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

7.  Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Authors:  F Y Lin; P H Azimi; L E Weisman; J B Philips; J Regan; P Clark; G G Rhoads; J Clemens; J Troendle; E Pratt; R A Brenner; V Gill
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

8.  Infected chylothorax caused by Streptococcus agalactiae: a case report.

Authors:  J T Wang; P R Hsueh; W H Sheng; S C Chang; K T Luh
Journal:  J Formos Med Assoc       Date:  2000-10       Impact factor: 3.282

9.  Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.

Authors:  K T Luh; P R Hsueh; L J Teng; H J Pan; Y C Chen; J J Lu; J J Wu; S W Ho
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

10.  Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-05-31
View more
  23 in total

1.  Antimicrobial susceptibilities of group B streptococci in New Zealand.

Authors:  Anja M Werno; Trevor P Anderson; David R Murdoch
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci.

Authors:  Patrick Tang; Peter Ng; Ming Lum; Martin Skulnick; Glen W Small; Donald E Low; Alicia Sarabia; Tony Mazzulli; Katherine Wong; Andrew E Simor; Barbara M Willey
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.

Authors:  Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

4.  Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources.

Authors:  Rafael S Duarte; Bruna C Bellei; Otávio P Miranda; Maria A V P Brito; Lúcia M Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Kouji Kimura; Kiyoko Tamai; Hideji Yanagisawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

6.  Group B streptococcal disease in nonpregnant patients: emergence of highly resistant strains of serotype Ib in Taiwan in 2006 to 2008.

Authors:  Ying-Hsiang Wang; Lin-Hui Su; Jiun-Nun Hou; Tsung-Han Yang; Tzou-Yien Lin; Chishih Chu; Cheng-Hsun Chiu
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

7.  Pattern of infection and antibiotic activity among Streptococcus agalactiae isolates from adults in Mashhad, Iran.

Authors:  Masoumeh Malek-Jafarian; Fatemeh-Sadat Hosseini; Abodol-Reza Ahmadi
Journal:  Rep Biochem Mol Biol       Date:  2015-04

8.  Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.

Authors:  Jussara K Palmeiro; Libera M Dalla-Costa; Sérgio E L Fracalanzza; Ana C N Botelho; Keite da Silva Nogueira; Mara C Scheffer; Rosângela S L de Almeida Torres; Newton Sérgio de Carvalho; Laura Lúcia Cogo; Humberto M F Madeira
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

9.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

10.  Changing molecular epidemiology of group B streptococcus in Korea.

Authors:  Yong Soo Seo; Usha Srinivasan; Kwan-Young Oh; Jung-Hwan Shin; Jeong Don Chae; Moon Young Kim; Jae Hyug Yang; Hye-Ryung Yoon; Brady Miller; Joan DeBusscher; Betsy Foxman; Moran Ki
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.